234 related articles for article (PubMed ID: 22944049)
1. PRAME expression in head and neck cancer correlates with markers of poor prognosis and might help in selecting candidates for retinoid chemoprevention in pre-malignant lesions.
Szczepanski MJ; DeLeo AB; Łuczak M; Molinska-Glura M; Misiak J; Szarzynska B; Dworacki G; Zagor M; Rozwadowska N; Kurpisz M; Krzeski A; Kruk-Zagajewska A; Kopec T; Banaszewski J; Whiteside TL
Oral Oncol; 2013 Feb; 49(2):144-51. PubMed ID: 22944049
[TBL] [Abstract][Full Text] [Related]
2. Model examination of chemoprevention with retinoids in squamous cell carcinomas of the head and neck region and suitable biomarkers for chemoprevention.
Fabricius EM; Kruse-Boitschenko U; Schneeweiss U; Wildner GP; Hoffmeister B; Raguse JD
Int J Oncol; 2011 Nov; 39(5):1083-97. PubMed ID: 21785820
[TBL] [Abstract][Full Text] [Related]
3. [Expression of retinoic acid receptors in head and neck squamous cell carcinomas and their possible implication for chemoprevention].
Issing WJ
Laryngorhinootologie; 2001 Sep; 80(9):530-4. PubMed ID: 11555786
[TBL] [Abstract][Full Text] [Related]
4. COX-2 expression in dysplasia of the head and neck: correlation with elF4E.
Nathan CO; Leskov IL; Lin M; Abreo FW; Shi R; Hartman GH; Glass J
Cancer; 2001 Oct; 92(7):1888-95. PubMed ID: 11745262
[TBL] [Abstract][Full Text] [Related]
5. Expression and clinical significance of the Kv3.4 potassium channel subunit in the development and progression of head and neck squamous cell carcinomas.
Menéndez ST; Rodrigo JP; Allonca E; García-Carracedo D; Alvarez-Alija G; Casado-Zapico S; Fresno MF; Rodríguez C; Suárez C; García-Pedrero JM
J Pathol; 2010 Aug; 221(4):402-10. PubMed ID: 20593490
[TBL] [Abstract][Full Text] [Related]
6. Expression of cancer testis antigens in head and neck squamous cell carcinomas.
Figueiredo DL; Mamede RC; Proto-Siqueira R; Neder L; Silva WA; Zago MA
Head Neck; 2006 Jul; 28(7):614-9. PubMed ID: 16475205
[TBL] [Abstract][Full Text] [Related]
7. Plasminogen activator inhibitor-2: a molecular biomarker for head and neck cancer progression.
Hasina R; Hulett K; Bicciato S; Di Bello C; Petruzzelli GJ; Lingen MW
Cancer Res; 2003 Feb; 63(3):555-9. PubMed ID: 12566295
[TBL] [Abstract][Full Text] [Related]
8. Elevated PRAME expression: what does this mean for treatment of head and neck squamous cell carcinoma?
Szczepanski MJ; Whiteside TL
Biomark Med; 2013 Aug; 7(4):575-8. PubMed ID: 23905893
[No Abstract] [Full Text] [Related]
9. Potentially novel candidate biomarkers for head and neck squamous cell carcinoma identified using an integrated cell line-based discovery strategy.
Sepiashvili L; Hui A; Ignatchenko V; Shi W; Su S; Xu W; Huang SH; O'Sullivan B; Waldron J; Irish JC; Perez-Ordonez B; Liu FF; Kislinger T
Mol Cell Proteomics; 2012 Nov; 11(11):1404-15. PubMed ID: 22918226
[TBL] [Abstract][Full Text] [Related]
10. Elevated expression of iASPP in head and neck squamous cell carcinoma and its clinical significance.
Liu Z; Zhang X; Huang D; Liu Y; Zhang X; Liu L; Li G; Dai Y; Tan H; Xiao J; Tian Y
Med Oncol; 2012 Dec; 29(5):3381-8. PubMed ID: 22815155
[TBL] [Abstract][Full Text] [Related]
11. Pattern and clinical significance of cancer-testis gene expression in head and neck squamous cell carcinoma.
Cuffel C; Rivals JP; Zaugg Y; Salvi S; Seelentag W; Speiser DE; Liénard D; Monnier P; Romero P; Bron L; Rimoldi D
Int J Cancer; 2011 Jun; 128(11):2625-34. PubMed ID: 20715104
[TBL] [Abstract][Full Text] [Related]
12. Expression of SGLT-1 in preneoplastic and neoplastic lesions of the head and neck.
Helmke BM; Reisser C; Idzko M; Dyckhoff G; Herold-Mende C
Oral Oncol; 2004 Jan; 40(1):28-35. PubMed ID: 14662412
[TBL] [Abstract][Full Text] [Related]
13. Expression of retinoic acid receptors in squamous cell carcinomas and their possible implication for chemoprevention.
Issing WJ; Wustrow TP
Anticancer Res; 1996; 16(4C):2373-7. PubMed ID: 8816837
[TBL] [Abstract][Full Text] [Related]
14. Expression and Prognostic Relevance of GAGE1 and XAGE1 Cancer/Testis Antigens in Head and Neck Squamous Cell Carcinoma.
Karia BTR; Zamuner FT; Carlin V; de Oliveira CZ; Carvalho AL; Vettore AL
Curr Mol Med; 2017; 17(10):707-717. PubMed ID: 29577858
[TBL] [Abstract][Full Text] [Related]
15. Prevention of head and neck squamous cell carcinoma: removing the "chemo" from "chemoprevention".
Saba NF; Haigentz M; Vermorken JB; Strojan P; Bossi P; Rinaldo A; Takes RP; Ferlito A
Oral Oncol; 2015 Feb; 51(2):112-8. PubMed ID: 25434586
[TBL] [Abstract][Full Text] [Related]
16. Suppression of squamous cell carcinoma growth and differentiation by retinoids.
Lotan R
Cancer Res; 1994 Apr; 54(7 Suppl):1987s-1990s. PubMed ID: 8137325
[TBL] [Abstract][Full Text] [Related]
17. RAR beta2 suppression in head and neck squamous cell carcinoma correlates with site, histology and age.
Olasz J; Juhász A; Remenár E; Engi H; Bak M; Csuka O; Kásler M
Oncol Rep; 2007 Jul; 18(1):105-12. PubMed ID: 17549354
[TBL] [Abstract][Full Text] [Related]
18. Hypermethylation of the retinoic acid receptor-beta(2) gene in head and neck carcinogenesis.
Youssef EM; Lotan D; Issa JP; Wakasa K; Fan YH; Mao L; Hassan K; Feng L; Lee JJ; Lippman SM; Hong WK; Lotan R
Clin Cancer Res; 2004 Mar; 10(5):1733-42. PubMed ID: 15014026
[TBL] [Abstract][Full Text] [Related]
19. Retinoids and their receptors in modulation of differentiation, development, and prevention of head and neck cancers.
Lotan R
Anticancer Res; 1996; 16(4C):2415-9. PubMed ID: 8816844
[TBL] [Abstract][Full Text] [Related]
20. Melanoma differentiation-associated gene-7/interleukin-24 as a potential prognostic biomarker and second primary malignancy indicator in head and neck squamous cell carcinoma patients.
Wang L; Feng Z; Wu H; Zhang S; Pu Y; Bian H; Wang Y; Guo C
Tumour Biol; 2014 Nov; 35(11):10977-85. PubMed ID: 25091574
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
